Publications are listed according to year, with the most recent first. Within each year, publications are listed in alphabetical order, based on the first author’s surname. Click on “Publication link” to access the publication on PubMed. Use the search box above to find particular publications based on author or terms in the title.
Wilms’ Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses
Uttenthal B, Martinez-Davila I, Ivey A, Craddock C, Chen F, Virchis A, Kottaridis P, Grimwade D, Khwaja A, Stauss H, Morris EC.
Br J Haematol. 2014 Feb;164(3):366-75.
Shear stress regulated gene expression and angiogenesis in vascular endothelium
Wragg JW, Durant S, McGettrick HM, Sample KM, Egginton S, Bicknell R.
Microcirculation 2014 Jan 28.
Blockade of TGF-beta signaling greatly enhances the efficacy of TCR gene therapy of cancer.
Bendle GM, Linnemann C, Bies L, Song JY, Schumacher TN.
J Immunol. 2013 Sep 15;191(6):3232-9.
HLA-peptide multimer selection of adenovirus-specific T cells for adoptive T-cell therapy
Chakupurakal G, Onion D, Bonney S, Cobbold M, Mautner V, Moss P.
J Immunother. 2013 Oct;36(8):423-31.
Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
Craddock C, Quek L, Goardon N, Freeman S, Siddique S, Raghavan M, Aztberger A, Schuh A, Grimwade D, Ivey A, Virgo P, Hills R, McSkeane T, Arrazi J, Knapper S, Brookes C, Davies B, Price A, Wall K, Griffiths M, Cavenagh J, Majeti R, Weissman I, Burnett A, Vyas P.
Leukemia. 2013 Apr;27(5):1028-36.
Prognostic relevance of treatment response measured by flow cytometric residual disease detection in older patients with acute myeloid leukemia
Freeman SD, Virgo P, Couzens S, Grimwade D, Russell N, Hills RK, Burnett AK.
J Clin Oncol. 2013 Nov 10;31(32):4123-31